Link copied to clipboard!

Aster DM Healthcare, Faruk Medical City sign contract to develop health services in Iraq

IMT News Desk
IMT News Desk
· 3 min read

A unique initiative to be introduced in the country would see Faruk Medical City (FMC) and Aster combine their strengths to develop Iraq’s healthcare sector

Aster DM Healthcare signed a Contract with Faruk Medical City, Iraq’s leading healthcare service provider, to collaborate on capability development and academic and professional training programmes for clinical staff and healthcare professionals in Iraq. Faruk Medical City is a part of Faruk Investment Group – one of the largest investment groups in Iraq.

Through this partnership, doctors from Aster DM Healthcare will visit Faruk Medical City’s state-of-the-art facilities to consult and provide surgical services which are not locally available and for which patients have to travel overseas. 

Aster DM Healthcare and Faruk Medical City will jointly provide training and academic support to the medical and paramedical staff of Faruk Medical City hospital. The move aims to develop Faruk Medical City jointly as a hospital of excellence through providing advanced academic training and capability development, along with its benchmarked international standards in providing first-rated clinical and medical services in Iraq. Aster will also play an advisory role in guiding Faruk Medical City to apply for international accreditation.

Faruk Investment Group and Aster DM Healthcare have also signed a Memorandum of Understanding to explore potential collaboration opportunities to expand Aster Pharmacy’s services to Iraq, including the distribution and retail of pharmaceutical and wellness products. 

Dr Azad Moopen, Founder Chairman and MD, Aster DM Healthcare, said, “We are pleased to partner with FMC Kurdistan to support the clinical operations and academic programmes at FMC Hospitals, Sulaimaniya. With decades of experience in providing tertiary and quaternary patient care, Aster is well-placed to provide comprehensive training to healthcare professionals in Iraq. Our expert doctors shall also visit FMC regularly to participate in patient care. This partnership reaffirms Aster’s commitment to supporting patients and the medical fraternity across geographies.” 

Faruk Mustafa Rasool, Founder and Chairman, Faruk Investment Group and Faruk Medical City said, “We are delighted to announce this new partnership with Aster DM Healthcare, and we are looking forward to working together to upscale and develop our healthcare service all over Iraq. With Aster, we will build synergies on all medical and administrative levels to improve hospital operations and clinical services through the joining of the strengths of Faruk Investment Group’s 45-year-long history in business leadership in Iraq, Faruk Medical City’s strong presence and brand presence as a leader in healthcare services in Iraq, and Aster through their successful 36-years-long leadership in healthcare provision in the GCC and India. We are envisaging further developing the healthcare sector in Iraq through active contribution to medical education in the fields of Nursing, and Biomedical sciences.”

 

Read Next

Agenus announces closing of $141 M strategic collaboration with Zydus Lifesciences
Global News
January 20, 2026

Agenus announces closing of $141 M strategic collaboration with Zydus Lifesciences

To advance BOT+BAL and strengthen US manufacturing readiness Agenus, a leader in immuno-oncology innovation, announced the closing of its previously disclosed strategic collaboration with Zydus Lifesciences Ltd. The agreement is designed to accelerate global development and potential commercialisation of Agenus’ botensilimab and balstilimab (BOT+BAL) immunotherapy combination programme. The collaboration provides Agenus with strategic capital and […]
Article by: IMT News Desk
Venus Remedies secures marketing authorisation for Ceftazidime + Avibactam in Indonesia
Global News
January 16, 2026

Venus Remedies secures marketing authorisation for Ceftazidime + Avibactam in Indonesia

Approval marks Venus Remedies’ first anti-infective marketing authorisation in Indonesia and enables the country’s first generic entry for this critical antibiotic combination Venus Remedies has secured the marketing authorisation from the Indonesian regulatory authority for its combination antibiotic, Ceftazidime + Avibactam. This approval represents Venus Remedies’ first marketing authorization in the anti-infective segment in Indonesia […]
Article by: IMT News Desk
Wegovy pill approved in the US for weight management
Global News
December 26, 2025

Wegovy pill approved in the US for weight management

Novo Nordisk expects to launch the Wegovy pill in the US in early January 2026 Novo Nordisk announced that the US Food and Drug Administration (FDA) has approved the Wegovy pill (once-daily oral semaglutide 25 mg) to reduce excess body weight and maintain weight reduction long term and to reduce the risk of major adverse […]
Article by: IMT News Desk
Samsung Biologics America in agreement to acquire 100 per cent of Human Genome Sciences from GSK
Global News
December 24, 2025

Samsung Biologics America in agreement to acquire 100 per cent of Human Genome Sciences from GSK

Under the terms of the agreement, with closing anticipated toward the end of Q1 of 2026, Samsung Biologics will acquire the Rockville assets for $280 million Samsung Biologics, a leading contract development and manufacturing organization (CDMO), announced that its wholly owned US subsidiary, Samsung Biologics America, has entered into a definitive agreement to acquire 100 […]
Article by: IMT News Desk